PetMed Express Inc (PETS) stock
PETSNasdaqRetail-Drug Stores and Proprietary StoresFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3063% below fair value
$0.94−0.05 (-4.96%)
Close on Nov 13, 2026Market cap $20.38MP/E –Yield 0.00%
PetMed Express r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for PetMed Express
PetMed Express has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?